BlackRock Investment Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.61M	Sell	142,579 -7,224	-5%	-$241K	0.01%	1638
2016 Q3	$5.13M	Buy	149,803 +14,348	+11%	+$562K	0.01%	1464
2016 Q2	$4.57M	Buy	135,455 +9,206	+7%	+$452K	0.01%	1497
2016 Q1	$6.69M	Buy	126,249 +3,612	+3%	+$211K	0.01%	1182
2015 Q4	$9.42M	Buy	122,637 +135	+0.1%	+$7.64K	0.01%	969
2015 Q3	$5.04M	Sell	122,502 -1,224	-1%	-$75K	0.01%	1371
2015 Q2	$8.75M	Buy	123,726 +25,338	+26%	+$2M	0.01%	1088
2015 Q1	$8.74M	Buy	98,388 +1,428	+1%	+$145K	0.01%	1026
2014 Q4	$8.6M	Sell	96,960 -4,016	-4%	-$380K	0.01%	1035
2014 Q3	$9.79M	Buy	100,976 +3,569	+4%	+$347K	0.01%	924
2014 Q2	$8.95M	Buy	97,407 +21,347	+28%	+$1.63M	0.01%	1038
2014 Q1	$5.32M	Buy	76,060 +327	+0.4%	+$22.2K	0.01%	1322
2013 Q4	$4.35M	Sell	75,733 -1,969	-3%	-$104K	0.01%	1443
2013 Q3	$3.74M	Buy	77,702 +4,937	+7%	+$180K	0.01%	1481
2013 Q2	$2.11M	Buy	+72,765	New	+$2.1M	﹤0.01%	1817